XBiotech Inc Capital Reinvestment Ratio

Latest as of December 2022: 0.05x

XBiotech Inc capital reinvestment ratio. XBiotech Inc (XBIT) has a Capital Reinvestment Ratio of 0.05x as of December 2022, meaning it reinvests 0% of its operating cash flow ($2.70 Million) in capital expenditures ($132.00K). Check XBIT capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.05x
Capex / Operating Cash Flow

Operating Cash Flow

$2.70 Million
USD

Capital Expenditures

$132.00K
USD

Data as of

Dec 2022
Most recent filing

Capital Reinvestment Ratio of XBiotech Inc (2021–2021)

Capital reinvestment ratio of XBiotech Inc from 2021 to 2021. This chart tracks XBiotech Inc's Capital Reinvestment Ratio across 1 annual periods. Also explore XBiotech Inc (XBIT) equity growth momentum to track the company's year-over-year net asset growth rate.

XBiotech Inc Capital Reinvestment Ratio by Year (2021–2021)

XBiotech Inc capital reinvestment ratio by year from 2021 to 2021. For the full cash flow conversion analysis, see how efficiently does XBiotech Inc generate cash.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2021 0.05x $69.44 Million $3.52 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow